Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP8RX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,956
Award facts
- Contract value 100% obligated
- $20,955.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,955.50 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Wegovy 2.4 mg/0.75 mL pens. This is a firm fixed-price, non-set-aside contract with a completion date of January 16, 2026, and performance location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a wide range of prescription medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, continues to demonstrate its capacity to fulfill federal medical procurement requirements through competitive procurement. The company's extensive portfolio of federal contract awards with DLA reflects its critical role in supplying specialized pharmaceutical products, including diabetes medications and other therapeutic commodities, to support Defense Health Agency operations and military treatment facilities. This award exemplifies the company's ongoing capability to deliver essential medications efficiently to federal healthcare systems through established contract vehicles.
Quick answers
Who was awarded contract SPE2DR26FP8RX?
SPE2DR26FP8RX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FP8RX worth?
The government has obligated $20,956 on SPE2DR26FP8RX.
Is contract SPE2DR26FP8RX an order under another contract?
Yes. SPE2DR26FP8RX is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8RX competed?
The extent of competition for SPE2DR26FP8RX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award